Frèdèrique Menzaghi
Keine laufenden Positionen mehr
Vermögen: 152 195 $ am 31.03.2024
Profil
Frèdèrique Menzaghi is the founder of CARA Therapeutics, Inc. founded in 2004, where she held the title of Chief Scientific Officer and Senior VP-R&D until 2024.
She is also the founder of Sibia Neurosciences, Inc. Dr. Menzaghi's former jobs include Director-In Vivo Pharmacology at Arena Pharmaceuticals, Inc. from 1999 to 2003, Principal at Eli Lilly & Co., and Vice President-Pharmacology & Business Development at Psychogenics, Inc. from 2003 to 2004.
Dr. Menzaghi received a doctorate from the University of Strasbourg and a graduate degree from Ecole des Mines de Nancy.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
CARA THERAPEUTICS INC
0,31% | 01.02.2024 | 167 247 ( 0,31% ) | 152 195 $ | 31.03.2024 |
Ehemalige bekannte Positionen von Frèdèrique Menzaghi
| Unternehmen | Position | Ende |
|---|---|---|
| CARA THERAPEUTICS, INC. | Founder | 02.02.2024 |
Psychogenics, Inc.
 Psychogenics, Inc. Pharmaceuticals: MajorHealth Technology Psychogenics, Inc. specializes in preclinical neurobiology solutions. It offers animal models, behavioral tests, histology/immunohistochemistry, microdialysis/bioanalysis, electrophysiology, molecular biology and pharmacology. The company was founded by Eric Nestler, Benjamin S. Bunney and Daniel Goodman and is headquartered in Paramus, NJ. | Corporate Officer/Principal | 01.01.2004 |
| ARENA PHARMACEUTICALS | Corporate Officer/Principal | 01.01.2003 |
| Sibia Neurosciences, Inc. | Founder | - |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | - |
Ausbildung von Frèdèrique Menzaghi
| University of Strasbourg | Doctorate Degree |
| Ecole des Mines de Nancy | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| ELI LILLY AND COMPANY | Health Technology |
| CARA THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
| Sibia Neurosciences, Inc. | Health Technology |
Arena Pharmaceuticals, Inc.
 Arena Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Arena Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel drugs that target G protein-coupled receptors. It offers drugs for treatment in the field of cardiovascular, central nervous system, inflammatory, and metabolic diseases. The company was founded by Dominic P. Behan and Jack Lief on April 14, 1997 and is headquartered in Park City, UT. | Health Technology |
Psychogenics, Inc.
Psychogenics, Inc. Pharmaceuticals: MajorHealth Technology Psychogenics, Inc. specializes in preclinical neurobiology solutions. It offers animal models, behavioral tests, histology/immunohistochemistry, microdialysis/bioanalysis, electrophysiology, molecular biology and pharmacology. The company was founded by Eric Nestler, Benjamin S. Bunney and Daniel Goodman and is headquartered in Paramus, NJ. | Health Technology |
